Cairo-based startup Grinta, a fintech-enabled B2B tech platform digitising the pharmaceutical supply chain, has raised an undisclosed amount of funding and made a key acquisition as it plans further expansion.
Founded in 2021 by Mohamed Azab, Yosra Badr, Ali Youssef, and Hamza Mohamed, Grinta is a managed marketplace that modernises the pharmaceutical supply chain by empowering independent pharmacies. The end-to-end platform provides access to the full spectrum of traceable pharmaceutical and medical products from multiple vendors in addition to providing fulfillment, demand planning, and inventory financing.
The company is working with all stakeholders across the value chain, manufacturers, distributors, wholesalers, and pharmacies, to build a data-driven, reliable, and efficient pharmaceutical supply chain.
Grinta raised a US$8 million seed round in late-2022, and then acquired Auto-Cure, a B2B e-commerce platform, in 2023, and it has now raised further funding and made a further acquisition.
It has now secured an undisclosed amount of strategic investment in a funding round led by Beltone Venture Capital and Raed Ventures, while also announcing its acquisition of Citi Clinic, one of Egypt’s most successful primary healthcare service chains.
The acquisition grants Grinta access to over 150,000 patients, marking its entry into the care sector and reinforcing its commitment to integrating both online and offline healthcare solutions.
“The acquisition of Citi Clinic is a pivotal moment for Grinta. It not only enables us to enter the care market but also allows us to integrate offline and online services to transform the way healthcare is accessed and delivered. We are excited about what lies ahead as we expand our reach and impact,” said Mohamed Azab, co-founder and CEO of Grinta.
